Nxera Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	111,178	74,839	94,216	127,103	175,151	155,210
Market Cap Growth	70.58%	-20.57%	-25.87%	-27.43%	12.85%	7.00%
Enterprise Value	155,411	109,518	114,757	158,025	143,645	134,496
Last Close Price	1212.00	827.00	1048.00	1421.00	2138.00	1904.00
PE Ratio	-	-	-	-	458.51	152.62
Forward PE	23.69	14.88	48.75	62.51	62.98	37.67
PS Ratio	3.25	2.53	3.27	9.96	11.25	8.76
PB Ratio	1.75	1.23	1.38	1.90	3.02	2.70
P/TBV Ratio	-	-	-	-	5.14	4.67
P/FCF Ratio	-	-	-	-	18.10	22.49
P/OCF Ratio	-	-	-	-	17.60	21.88
EV/Sales Ratio	4.54	3.70	3.98	12.38	9.23	7.59
EV/EBITDA Ratio	119.27	-	-	-	34.56	16.43
EV/EBIT Ratio	-	-	-	-	51.08	19.46
EV/FCF Ratio	-27.86	-	-	-	14.85	19.49
Debt / Equity Ratio	0.88	0.94	0.99	1.11	0.51	0.51
Debt / EBITDA Ratio	41.05	-	-	-	7.15	3.57
Debt / FCF Ratio	-	-	-	-	3.07	4.24
Net Debt / Equity Ratio	0.70	0.61	0.46	0.37	-0.64	-0.54
Net Debt / EBITDA Ratio	32.52	-9.48	-12.01	-3.14	-8.86	-3.76
Net Debt / FCF Ratio	-7.93	-11.88	-3.84	-4.10	-3.81	-4.46
Asset Turnover	0.25	0.21	0.19	0.10	0.16	0.20
Inventory Turnover	0.77	0.81	1.30	-	-	-
Quick Ratio	1.73	1.83	3.04	3.55	16.90	8.67
Current Ratio	2.61	2.54	3.70	3.79	17.09	8.73
Return on Equity (ROE)	-15.26%	-19.35%	-7.15%	-11.53%	0.66%	1.85%
Return on Assets (ROA)	-1.35%	-3.61%	-2.68%	-5.07%	1.79%	4.98%
Return on Invested Capital (ROIC)	-2.94%	-8.34%	-6.90%	-18.43%	4.17%	24.83%
Return on Capital Employed (ROCE)	-2.60%	-7.10%	-4.90%	-7.40%	2.90%	7.70%
Earnings Yield	-8.97%	-16.74%	-5.13%	-5.66%	0.22%	0.66%
FCF Yield	-5.02%	-4.16%	-8.75%	-4.78%	5.52%	4.45%
Buyback Yield / Dilution	-0.65%	-0.61%	-8.74%	0.09%	-0.71%	-3.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.